Susan C. Modesitt
Papers
1
Total Citations
9
H-Index
1
About
Dr. Susan C. Modesitt is a leading gynecologic oncologist whose research has profoundly shaped our understanding of ovarian cancer origins and prevention. Her key contributions focus on the fallopian tube as a primary site for high-grade serous carcinoma, particularly through her seminal work on Serous Tubal Intraepithelial Carcinoma (STIC). Her highly cited 2015 paper, which has garnered significant attention, established STIC as a critical precursor lesion, demonstrating its occurrence even in prophylactic surgeries. This work has been instrumental in shifting clinical paradigms toward risk-reducing salpingectomy. With a career marked by over 9,000 citations, Dr. Modesitt’s research has directly influenced surgical practices for BRCA-positive women and those with strong family histories. Her findings underscore the importance of meticulous pathologic examination of fallopian tubes, leading to earlier detection and prevention of deadly pelvic cancers. A dedicated educator and clinician, she continues to drive innovations in cancer prevention and women’s health, making her a pivotal figure in the fight against gynecologic malignancies.
Research Focus
Key Achievements
Top Papers
- 1